This company listing is no longer active
002435 Stock Overview
Changjiang Runfa Health Industry Co., Ltd. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Changjiang Runfa Health Industry Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥0.37 |
52 Week High | CN¥4.92 |
52 Week Low | CN¥0.37 |
Beta | 0.18 |
11 Month Change | 0% |
3 Month Change | -78.36% |
1 Year Change | -92.06% |
33 Year Change | -92.75% |
5 Year Change | -91.63% |
Change since IPO | -92.70% |
Recent News & Updates
Recent updates
Shareholder Returns
002435 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 0% | -1.5% | -2.1% |
1Y | -92.1% | -9.4% | 2.8% |
Return vs Industry: 002435 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.
Return vs Market: 002435 underperformed the CN Market which returned -19% over the past year.
Price Volatility
002435 volatility | |
---|---|
002435 Average Weekly Movement | 0.9% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 002435's share price has been volatile over the past 3 months.
Volatility Over Time: 002435's weekly volatility has decreased from 7% to 1% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 2,236 | n/a | www.cjrfjx.com |
Changjiang Runfa Health Industry Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It also provides specialized medical services for obstetrics and gynecology; and produces and sells mechanical products, such as elevator guide rails.
Changjiang Runfa Health Industry Co., Ltd. Fundamentals Summary
002435 fundamental statistics | |
---|---|
Market cap | CN¥457.31m |
Earnings (TTM) | -CN¥836.94m |
Revenue (TTM) | CN¥3.02b |
0.2x
P/S Ratio-0.5x
P/E RatioIs 002435 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002435 income statement (TTM) | |
---|---|
Revenue | CN¥3.02b |
Cost of Revenue | CN¥2.20b |
Gross Profit | CN¥829.64m |
Other Expenses | CN¥1.67b |
Earnings | -CN¥836.94m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
Earnings per share (EPS) | -0.68 |
Gross Margin | 27.43% |
Net Profit Margin | -27.67% |
Debt/Equity Ratio | 56.6% |
How did 002435 perform over the long term?
See historical performance and comparison